Regeneron VP Neil Stahl disclosed the sale of 11,665 shares of company stock at $840.98 per share on August 22, for a total transaction amount of $9,810,083.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on REGN:
- Regeneron Announces Investor Conference Presentations
- Biotech Alert: Searches spiking for these stocks today
- Regeneron confirms $326M BARDA funding for Covid antibody therapy
- Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
- Regeneron awarded $326M from U.S. for next-generation COVID antibody